Newsroom

Tabletten
News
Be Better Prepared for Pandemics
The German Center for Infection Research (DZIF) and the Helmholtz Centre for Infection Research (HZI) have developed a concept to form a National Alliance for Pandemic Therapeutics (NA-PATH). They thereby wish to target research and development of widely effective therapeutics in order to be better prepared for future outbreaks due to viral pathogens having pandemic potential. Overcoming the current COVID-19 pandemic will be considerably more difficult due to the deficiency of antiviral active substances.
06.10.2021
HZI Campus
Raserelektronenmikroskopische Aufnahme von Klebsiella pneumoniae
News
Quest for bacterial cocktails to fight infections
04.10.2021
HZI Campus
Infographic
Story
Exploring humans, animals and the environment as one
The Helmholtz Institute for One Health is a new HZI location in Greifswald, linking research into human and animal health with environmental factors.
04.10.2021
HIOH
Gruppenbild
News
From basic research to the clinic: new centre strengthens drug research in Saarland
It often takes many years before a new active compound from basic research hits the market as a drug. In order to accelerate this process, the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) and Saarland University will work together even more closely in the future. To this end, they have now founded the Translational Centre for Bioactive Compounds, in which scientists from both institutions will interact closely with the University Hospital in Homburg and the pharmaceutical industry.
02.10.2021
HIPS
Luca Cicin-Sain
Interview
Luka Cicin-Sain: “The immune response becomes inefficient with age”
In the coronavirus pandemic, older people are particularly at risk from severe courses of COVID-19. However, other infectious diseases also affect them more than younger people. On the occasion of the International Day of Older Persons on 1 October, Prof Luka Cicin-Sain, Head of the Department "Viral Immunology", talks about the ageing of the immune system.
30.09.2021
HZI Campus
Logos HZI und EMBL
News
Stronger together: EMBL and Helmholtz Health formalise their collaboration in research and development
EMBL and the six Helmholtz Centers of the Research Field Health (Helmholtz Health) are expanding their collaboration. The two research organisations are cooperating to expand the frontiers of health research and advance scientific progress for human health.
22.09.2021
HZI Campus

HZI in the media

Malaria: Neuer Wirkstoff dreht dem Parasiten den Protein-Hahn zu

Quelle: Pressemitteilung

 

HZI-Helmholtz Zentrum für Infektionsforschung ...

04.11.2025
|
LaborPraxis
Grippe-Schnelltest per Kaugummi

Forschende des Helmholtz-Zentrums für Infektionsforschung und der Universität Würzburg entwickeln derzeit einen Kaugummi, der Grippeviren

04.11.2025
|
Arbeitsmedizin-Sozialmedizin-Umweltmedizin
Eier und Geflügel gefahrlos verzehren? So können sich Menschen vor der Vogelgrippe schützen

... Vakzinologie und angewandte Mikrobiologie am Helmholtz-Zentrum für Infektionsforschung. Die M2-Membranproteinhemmer verhindern ...

02.11.2025
|
Augsburger Allgemeine
Pilze für die Gesundheit – was können „Vitalpilze“?

... etwas dran ist“, erklärt Biologe Marc Stadler vom Helmholtz-Zentrum für Infektionsforschung gegenüber der Barmer-Krankenkasse. „Es ...

30.10.2025
|
bild der wissenschaft
Vaccinated against polio—or not? Study finds differences between documented and self-reported vaccination rates

could be reintroduced at any time. Epidemiologists at the Helmholtz Center for Infection Research (HZI) have now shown that many people do

23.10.2025
|
MSN.com
Gegen Polio Geimpft: Fakten Und Mythen Im Überblick

... eingeschleppt werden könnte. Epidemiolog:innen des Helmholtz-Zentrums für Infektionsforschung (HZI) haben nun gezeigt, dass ...

23.10.2025
|
innovations report
New malaria drug candidate blocks protein production in resistant parasites

this development, a research team at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), in collaboration with the Swiss

22.10.2025
|
Phys.org
Neuer Wirkstoff schneidet Parasiten die Proteinzufuhr ab

Malaria-Medikamentes ermöglichen könnte. Das HIPS ist ein Standort des Helmholtz-Zentrums für Infektionsforschung in Zusammenarbeit mit ...

22.10.2025
|
Verband Deutscher Biologen e.V.
Innovative chemo-enzymatische Methode zur Herstellung von Furanoliden gegen Krebs und Bakterien

(Bild: DOI: 10.1021/jacs.5c08354 / Hips / CC BY 4.0) Wissenschaftler am Hips entwickelten eine Plattform zur Produktion von Furanoliden, die effektiv gegen Bakterien und Krebszellen wirken können und vielversprechende Wirkstoffe darstellen.

21.10.2025
|
PROCESS
Innovative Platform Developed for Producing Versatile Active Ingredients

at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), in partnership with the Helmholtz Centre for Infection Research (HZI

20.10.2025
|
Bioengineer.org
Enzyme-based system produces versatile active ingredients for drug discovery and testing

their biological activity. HIPS is a site of the Helmholtz Center for Infection Research (HZI) in collaboration with Saarland University.

20.10.2025
|
Phys.org
Nobelpreis für Physiologie und Medizin: Wer die Killer kontrolliert

... die Abteilung „Experimentelle Immunologie“ am Helmholtz-Zentrum für Infektionsforschung (HZI) in Braunschweig, lehrt als Professor an ...

17.10.2025
|
Deutsches Ärzteblatt

Register now for the HZI-Newsletter